Fermi Inc. (FRMI)
Live price chart, market sentiment, and community perspectives for Fermi Inc. (NASDAQ: FRMI).
Live price chart, market sentiment, and community perspectives for Fermi Inc. (NASDAQ: FRMI).
On our desk, the reaction to Fermi's $375 million convertible note issuance has been entirely negative from a governance perspective. The sudden resignation of director Miles Everson—explicitly citing a lack of access to board minutes and bypassed debate over the transaction—presents a glaring red flag for institutional risk management. While the headline numbers on the TensorWave lease look attractive, ignoring internal board friction and dilution risks at a time when six-month net losses have hit $214.50 million is a dangerous game. We are advising caution until management provides clear transparency on board oversight.
Watching the tape on FRMI, the volatility is staggering. The stock surged up to 35% after-hours following the announcement of the 15-year, $6.5 billion turnkey lease with TensorWave for 222 MW at Project Matador, but it quickly gapped down as traders digested the execution and financing realities. Net losses of $25.81 million in Q2 alone underscore the cash burn inherent in building out these massive behind-the-meter power complexes in Texas. Delivery doesn't even begin until the second half of 2027, leaving plenty of room for construction and financing headwinds to test investor patience.
From a technical and operational standpoint, our quantitative team is focusing closely on how Fermi plans to execute its infrastructure goals without getting bogged down by capital structure constraints. The company completed all five objectives in its 90-day plan—including securing Lee McIntire as CEO, forming a strategic power alliance, and receiving three F-Series turbines—which shows operational capability. However, balancing gigawatt-scale buildouts with Hillcore-financed power complexes while dealing with a 5% coupon on 2031 convertibles means analysts need to probe deeply into capital allocation efficiency during upcoming management calls.
Explore plasma cleansing, somatic organ swaps, and BCI.